Drug Interactions Database

3916 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
livevaccines teriflunomide

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
livevaccines tioguanine

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
livevaccines topotecan

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
livevaccines trabectedin

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
livevaccines vincaalkaloids

increases risk of generalisedinfection(possiblylife-threatening)

Unknown Theoretical
lomitapide atorvastatin

increases exposure

Unknown Study
lomitapide statins

increases exposure

Unknown Study
loperamide andpossiblysublingual

increases absorption

Unknown Study
loperamide oraldesmopressin

increases absorption

Unknown Study
lorlatinib aliskiren

decreases exposure

Unknown Study
lorlatinib antihistamines,non-sedating

decreases exposure

Unknown Study
lorlatinib ciclosporin

decreases exposure

Unknown Theoretical
lorlatinib colchicine

decreases exposure

Unknown Study
lorlatinib coumarins

decreases exposure

Unknown Theoretical
lorlatinib dabigatran

decreases exposure

Unknown Study
lorlatinib digoxin

decreases exposure

Unknown Study
lorlatinib ergotamine

decreases exposure

Unknown Theoretical
lorlatinib everolimus

decreases exposure

Unknown Study
lorlatinib fexofenadine

decreases exposure

Unknown Study
lorlatinib loperamide

decreases exposure

Unknown Study
lorlatinib midazolam

decreases exposure

Unknown Study
lorlatinib paclitaxel

decreases exposure

Unknown Study
lorlatinib pimozide

decreases exposure

Unknown Theoretical
lorlatinib sirolimus

decreases exposure

Unknown Theoretical
lorlatinib tacrolimus

decreases exposure

Unknown Theoretical
lorlatinib talazoparib

decreases exposure

Unknown Study
lorlatinib taxanes

decreases exposure

Unknown Study
lorlatinib thrombininhibitors

decreases exposure

Unknown Study
lorlatinib topotecan

decreases exposure

Unknown Study
loxapine dopaminereceptoragonists

decreases effects

Unknown Theoretical
loxapine levodopa

decreases effects

Unknown Theoretical
lumacaftor antifungals,azoles

decreases exposure

Unknown Theoretical
lumacaftor clarithromycin

decreases exposure

Unknown Theoretical
lumacaftor combinedhormonalcontraceptives

decreases exposure

Unknown Theoretical
lumacaftor desogestrel

decreases efficacy

Unknown Theoretical
lumacaftor erythromycin

decreases exposure

Unknown Theoretical
lumacaftor glecaprevir

decreases exposure

Unknown Theoretical
lumacaftor itraconazole

decreases exposure

Unknown Theoretical
lumacaftor ketoconazole

decreases exposure

Unknown Theoretical
lumacaftor levonorgestrel

decreases efficacy

Unknown Theoretical
lumacaftor macrolides

decreases exposure

Unknown Theoretical
lumacaftor norethisterone

decreases efficacy

Unknown Theoretical
lumacaftor pibrentasvir

decreases exposure

Unknown Theoretical
lumacaftor posaconazole

decreases exposure

Unknown Theoretical
lumacaftor sirolimus

decreases exposure

Unknown Theoretical
lumacaftor subdermaletonogestrel

decreases efficacy

Unknown Theoretical
lumacaftor ulipristal

decreases efficacy

Unknown Theoretical
lumacaftor voriconazole

decreases exposure

Unknown Theoretical
macrolides afatinib

increases exposure

Unknown Study
macrolides antimalarials

increases risk of seriouscardiovascularadverseeffects

Unknown Theoretical
Prev 1 ... 44 45 46 47 48 ... 79 Next
3916 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.